These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2616618)

  • 21. A new formulation concept for drugs with poor water solubility for parenteral application.
    Jürgens K; Müller BW
    Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
    Nerurkar J; Jun HW; Price JC; Park MO
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid chromatographic analysis of certain commercial formulations for non-opioid analgesics.
    Bhushan R; Gupta D; Mukherjee A
    Biomed Chromatogr; 2007 Dec; 21(12):1284-90. PubMed ID: 17642068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (Eudragit) by quasi-emulsion solvent diffusion method: effect of variables.
    Devrim B; Canefe K
    Acta Pol Pharm; 2006; 63(6):521-34. PubMed ID: 17438870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [How does ibuprofen affect alcohol degradation?].
    Ovesjö ML
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1986. PubMed ID: 19764377
    [No Abstract]   [Full Text] [Related]  

  • 26. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
    Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
    J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the analgesic efficacy of ibuprofen.
    Beaver WT
    Int J Clin Pract Suppl; 2003 Apr; (135):13-7. PubMed ID: 12723741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated stability of Ibuprofen-Eudragit RSPM sustained release tablets, IR and DSC solid stability testing.
    Abdel Rahman AA; Aboutaleb AE; Stamm A; Samy EM; Abdel-Rahman SI
    J Pharm Belg; 1993; 48(6):463-70. PubMed ID: 8133428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, pharmacological activity and hydrolytic behavior of ethylenediamine and benzathine conjugates of ibuprofen.
    Chatterjee NR; Kulkarni AA; Ghulekar SP
    Eur J Med Chem; 2008 Dec; 43(12):2819-23. PubMed ID: 18068271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
    Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of ethanol on the solubility, ionization and permeation characteristics of ibuprofen in silicone and human skin.
    Watkinson RM; Herkenne C; Guy RH; Hadgraft J; Oliveira G; Lane ME
    Skin Pharmacol Physiol; 2009; 22(1):15-21. PubMed ID: 19088498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant use of ibuprofen and aspirin.
    Food and Drug Administration U.S. Department of Health and Human Services
    J Pain Palliat Care Pharmacother; 2007; 21(2):73-4. PubMed ID: 17844731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties.
    Jiang B; Hu L; Gao C; Shen J
    Int J Pharm; 2005 Nov; 304(1-2):220-30. PubMed ID: 16182477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulations.
    Roberts M; Ford JL; MacLeod GS; Fell JT; Smith GW; Rowe PH; Dyas AM
    J Pharm Pharmacol; 2004 Mar; 56(3):299-305. PubMed ID: 15025854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates.
    Zhao X; Tao X; Wei D; Song Q
    Eur J Med Chem; 2006 Nov; 41(11):1352-8. PubMed ID: 16806590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ["Non-solvent shock agglomeration"--the technology of a new alternative method for determination of ibuprofen. 6. Stability of s(+)-ibuprofen].
    Möller T; Korsatko W
    Pharmazie; 2000 Jun; 55(6):449-53. PubMed ID: 10907254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers.
    Williams AC; Timmins P; Lu M; Forbes RT
    Eur J Pharm Sci; 2005 Nov; 26(3-4):288-94. PubMed ID: 16087323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.